日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Exposure-Response Relationships in Patients with Non-Small-Cell Lung Cancer and Other Solid Tumors Treated with Patritumab Deruxtecan (HER3-DXd)

帕特妥单抗德鲁替康（HER3-DXd）治疗非小细胞肺癌和其他实体瘤患者的暴露-反应关系

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.3674
Li, Li; Lee, Mark; Joshi, Rujuta; Xu, Yuan; Garcia, Ramon; Baron, Kyle; Anderson, Eric; Waterhouse, Tim; Sternberg, David; Shrestha, Pomy; Vaddady, Pavan; Abutarif, Malaz; Garimella, Tushar
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Within-chain parallelization-Giving Stan Jet Fuel for population modeling in pharmacometrics

链内并行化——为药物计量学中的群体建模提供 Stan Jet Fuel

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.13238
Davis, Casey; Vaddady, Pavan
发表日期：2025
文献求助 收藏

Application of the model-informed drug development paradigm to datopotamab deruxtecan dose selection for late-stage development

将基于模型的药物开发范式应用于达托泊单抗德鲁西特康后期研发的剂量选择

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.13058
Lu, Yasong; Liang, Shuang; Hong, Ying; Tajima, Naoyuki; Patel, Kashyap; Li, Hanbin; Wada, David R; Greenberg, Jon; Petrich, Adam; Zebger-Gong, Hong; Shuster, Dale; Vaddady, Pavan
发表日期：2024
文献求助 收藏

Population pharmacokinetic analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia

对新诊断的FLT3内部串联重复阳性急性髓系白血病患者进行quizartinib群体药代动力学分析

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70074
Vaddady, Pavan; Glatard, Anaïs; Smania, Giovanni; Nakayama, Shintaro; Inoue, Hiroyuki; Kurumaddali, Abhinav; Abutarif, Malaz; Zheng, Ming
FLT3
白血病
发表日期：2024
文献求助 收藏

Concentration-QTcF analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia

对新诊断的FLT3内部串联重复阳性急性髓系白血病患者进行quizartinib浓度-QTcF分析

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70065
Vaddady, Pavan; Smania, Giovanni; Nakayama, Shintaro; Inoue, Hiroyuki; Kurumaddali, Abhinav; Abutarif, Malaz; Zheng, Ming
FLT3
白血病
发表日期：2024
文献求助 收藏

ModVizPop: A shiny interface for empowering teams to perform interactive pharmacokinetic/pharmacodynamic simulations

ModVizPop：一个简洁美观的界面，使团队能够进行交互式药代动力学/药效动力学模拟。

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.12697
Vaddady, Pavan; Kandala, Bhargava
发表日期：2021
文献求助 收藏

Population Pharmacokinetic and Pharmacodynamic Analysis To Evaluate a Switch to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in People Living with HIV-1

群体药代动力学和药效学分析，以评估 HIV-1 感染者改用多拉韦林/拉米夫定/富马酸替诺福韦二吡呋酯的疗效

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00590-20
Vaddady, Pavan; Kandala, Bhargava; Yee, Ka Lai
HIV
炎症/感染
微生物学
发表日期：2020
文献求助 收藏

Dynamic time-kill curve characterization of spectinamide antibiotics 1445 and 1599 for the treatment of tuberculosis

动态时间杀菌曲线表征用于治疗结核病的光谱酰胺类抗生素 1445 和 1599

期刊:European Journal of Pharmaceutical Sciences
影响因子:4.7
doi:10.1016/j.ejps.2018.11.006
Vaddady, Pavan K; Trivedi, Ashit; Rathi, Chetan; Madhura, Dora B; Liu, Jiuyu; Lee, Richard E; Meibohm, Bernd
发表日期：2019
文献求助 收藏

Doravirine exposure and HIV-1 suppression after switching from an efavirenz-based regimen to doravirine/lamivudine/tenofovir disoproxil fumarate

从依非韦伦方案换用多拉韦林/拉米夫定/富马酸替诺福韦二吡呋酯方案后，多拉韦林暴露情况及HIV-1抑制情况

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.01298-19
Greaves, Wayne; Wan, Hong; Yee, Ka Lai; Kandala, Bhargava; Vaddady, Pavan; Hwang, Carey
HIV
微生物学
发表日期：2019
文献求助 收藏

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy

在健康受试者和接受稳定阿片类激动剂治疗的受试者中，艾尔巴韦或格拉佐普韦与丁丙诺啡/纳洛酮之间未观察到药代动力学相互作用。

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.12565
Feng, Hwa-Ping; Guo, Zifang; Caro, Luzelena; Marshall, William L; Liu, Fang; Panebianco, Deborah; Vaddady, Pavan; Barbour, April; Reitmann, Christina; Jumes, Patricia; Gilmartin, Jocelyn; Wolford, Dennis; Valesky, Robert; Martinho, Monika; Butterton, Joan R; Iwamoto, Marian; Fraser, Iain; Webster, Lynn; Yeh, Wendy W
发表日期：2018
文献求助 收藏